11741 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2009)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3307)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (236)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11741)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N. U.; Moy, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM)
    Meeting Abstract

    Carvajal, R. D.; Sosman, J. A.; Quevedo, F.; Milhem, M. M.; Joshua, A. M.; Kudchadkar, R. R.; Linette, G. P.; Gajewski, T.; Lutzky, J.; Lawson, D. H.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Uncontrolled confounding in studies of screening effectiveness: An example of colonoscopy
    Journal Article

    Eldridge, R. C.; Doubeni, C. A.; Fletcher, R. H.; Zauber, A. G.; Corley, D. A.; Doria-Rose, V. P.; Goodman, M.
    Journal of Medical Screening (2013)

    Fulltext@MSK | Save
  • A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients
    Journal Article

    Correa, D. D.; Root, J. C.; Baser, R.; Moore, D.; Peck, K. K. ; Lis, E.; Shore, T. B.; Thaler, H. T.; Jakubowski, A.; Relkin, N.
    Brain Imaging and Behavior (2013)

    Fulltext@MSK | Save
  • Chemotherapy-induced amenorrhea: A prospective study of brain activation changes and neurocognitive correlates
    Journal Article

    Conroy, S. K.; McDonald, B. C.; Ahles, T. A.; West, J. D.; Saykin, A. J.
    Brain Imaging and Behavior (2013)

    Fulltext@MSK | Save
  • A prospective study investigating adherence and confidence with vaginal dilator use following pelvic and intravaginal radiotherapy
    Meeting Abstract

    Law, E.; Kelvin, J.; Thom, B.; Riedel, E.; Tom, A.; Goodman, K.
    Oncology Nursing Forum (2013)

    Fulltext@MSK | Save
  • Concordance between symptomatic adverse event ratings by clinicians and patients: A systematic review
    Meeting Abstract

    Ryan, S.; Atkinson, T. M.; Bennett, A. V.; Jewell, S.; Wagner, J. S.; Basch, E.
    Quality of Life Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Impact of trastuzumab-induced cardiotoxicity and cubsequent trastuzumab interruption on breast cancer outcome
    Meeting Abstract

    Yu, A. F.; Yadav, N. U.; Manrique, C. R.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Circulation (2013)

    Fulltext@MSK | Save
  • Healthcare provider perspectives of fertility preservation in post-cancer treatment adolescent and young adult females
    Meeting Abstract

    Thom, B.
    International Journal of Qualitative Methods (2013)

    Fulltext@MSK | Save